Mainstream

Verve Therapeutics Gaap Eps Of $0.58 Beats By $0.11, Revenue Of $13.08m Beats By $8.84m

Verve Therapeutics GAAP EPS of -$0.58 beats by $0.11, revenue of $13.08M beats by $8.84M

Verve Therapeutics GAAP EPS of -$0.58 beats by $0.11, revenue of $13.08M beats by $8.84M

Post ContentvervRead More

You might also be interested in reading Amylyx Pharmaceuticals down 3%, announces stock offering.

February 27, 2025
In Mainstream